1-3 of 3
Sajida Kazi, MRCP, FRCPATH
Close
Sort by
Journal Articles

Outcomes after Third Party, Viral-Specific, Cytotoxic Lymphocytes for Immunosuppression- and Epstein-Barr Virus-Associated Lymphoproliferative Disease

Sajida Kazi, MRCP, FRCPATH, Abhinav Mathur, MBChB, Gwen M. Wilkie, BSc, MSc, Kirsty Cheal, BSc, MSc, Richard Battle, BSc, PhD, Neil McGowan, BSc, Emily Jane Hargreaves, BSc, David Turner, BSc, PhD, John D.M. Campbell, BSc, PhD, Marc Turner, BM, BCh, PhD FRCP, Mark A Vickers, MB ChB, DM, FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 3329.
https://doi.org/10.1182/blood-2018-99-114477
Published: 2018
Journal Articles

Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor

Sajida Kazi, MRCP, FRCPATH, Ann Kinga Malinowski, MD MSc, FRCSC, Clare Whitehead, Kevin H. M. Kuo, MDMSc, FRCPC, Lynda Harrington, Nancy Watts, Chen Wang, MD PhD FRCPC, Nadine Shehata, MD FRCPC, MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 5077.
https://doi.org/10.1182/blood-2018-99-114949
Published: 2018
Journal Articles

Pregnancy Outcomes in Patients with Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis

Dawn Maze, MDFRCPC,MSc, Sajida Kazi, MRCP, FRCPATH, Vikas Gupta, MD FRCP, FRCPath, Ann Kinga Malinowski, MD MSc, FRCSC, Rouhi Fazelzad, BSc, MISt, Prakesh S Shah, MSc, MBBS, MD DCH, MRCP, FRCPC, Nadine Shehata, MD FRCPC, MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3046.
https://doi.org/10.1182/blood-2018-99-118299
Published: 2018